DIA
Drug Information Association Logo

CURRENT INDUSTRY PRACTICE FOR BENEFIT/RISK GOVERNANCE

Track:
Benefit/Risk Management and Lifecycle Approach

Day & Time:
March 26, 4:00PM - 5:30PM (Central European Standard Time)

Session Number:
0304

Room Number:
Room E2

Type:
Session

Title:
CURRENT INDUSTRY PRACTICE FOR BENEFIT/RISK GOVERNANCE

Chair(s):
Anne Bouvier, PhD
Dir & Head Benefit-Risk Mgt. & Process Innovation
UCB, Belgium

Description:
A case study will be used to illustrate changes made to a company’s existing safety risk governance model to include expanded functional stakeholders necessary to align on a comprehensive benefit/risk characterisation. The session will also review the ongoing debate regarding the qualitative vs. quantitative methods used for benefit/risk evaluations and the importance of standardised process. Finally, an approach for achieving an integrated lifecycle approach to benefit/risk evaluation and the current industry practices in operationally addressing new requirements will be explored. Industry benchmarking data will be referenced to characterise current practices in organisation & governance, benefit/risk assessment processes, benefit/risk source data and the challenging areas for development.

Presentation(s) & Speaker(s):
A Case Study to Illustrate the Benefit/Risk Evaluation Process and Governance
Anne Bouvier, PhD
Dir & Head Benefit-Risk Mgt. & Process Innovation
UCB, Belgium

Evaluation of Qualitative Benefit/Risk Assessment Methods
Lesley Wise, PhD, MSc
Senior Director Global PV Risk Management
Takeda London , United Kingdom

Current Industry Best Practices and Achieving Lifecycle Integration
Sharmila Sabaratnam, PhD
Senior Consultant
WCI Consulting Limited, United Kingdom